Publication: Pandemic (H1N1) 2009 virus infection: Persistent viral shedding after Oseltamivir treatment
1
Issued Date
2011-10-01
Resource Type
ISSN
15322742
01634453
01634453
Other identifier(s)
2-s2.0-80052937991
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Infection. Vol.63, No.4 (2011), 295-299
Suggested Citation
Sawan Kanchana, Supannakhon Kanchana, Charas Chuntrakul, Kumthorn Malathum, Slinporn Prachayangprecha, Yong Poovorawan Pandemic (H1N1) 2009 virus infection: Persistent viral shedding after Oseltamivir treatment. Journal of Infection. Vol.63, No.4 (2011), 295-299. doi:10.1016/j.jinf.2011.08.005 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/12305
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Pandemic (H1N1) 2009 virus infection: Persistent viral shedding after Oseltamivir treatment
Other Contributor(s)
Abstract
Objectives: To study pandemic (H1N1) 2009 virological outcomes after Oseltamivir treatment in confirmed cases of pandemic (H1N1) 2009 virus infections. A hospital-based cohort study was conducted in south Thailand, between June and September 2009. Methods: Throat/swab specimens were tested by real-time reverse transcriptase polymerase chain reaction (rRT-PCR) for pandemic (H1N1) 2009. All 357 confirmed cases (122 inpatients, 235 outpatients), whose received a 5-day Oseltamivir treatment. Post-treatment virological follow-up was performed in 91 eligible cases. The NA gene was screened for the H275Y mutation responsible for Oseltamivir resistance. Results: Thirty-three of 91 patients (36%) had underlying diseases. The duration from the onset of illness to the detection of virus ranged 1-14 days (median 3 days). The rRT-PCR was positive on day 5 of treatment in 24 of 91 patients (26%). Patients with underlying diseases had a higher proportion of post-treatment positive test than those without underlying diseases (15/33 vs 9/58). The rRT-PCR-confirmed viruses detected in all 125 throat swab specimens did not show evidence suggesting Oseltamivir resistance. Conclusions: Prolonged presence of pandemic (H1N1) 2009 detected by rRT-PCR was found. An extended course of antiviral treatment should be considered in patients with underlying diseases and severe clinical symptoms. © 2011 The British Infection Association.
